|
Omalizumab effectively treated adults with severe refractory asthma
Healio Omalizumab was effective in treating adults with severe refractory asthma for up to 48 weeks, possibly exerting anti-inflammatory effects on small airways and reversing airway remodeling, according to recent study results. Researchers in Japan … |
View full post on asthma – Google News